6. Transforming Clinical Trial Research with Kenneth Getz and Taqiyya Alford

6. Transforming Clinical Trial Research with Kenneth Getz and Taqiyya Alford

This episode features two voices from the clinical trial industry: Kenneth Getz, the Executive Director at the Tufts Center for the Study of Drug Development and Taqiyya Alford, a Clinical Research Coordinator at Emory University. Both guests discussed the ongoing and future impacts of COVID-19 on clinical trials.

Ken Getz is the Director and a professor at the Tufts Center for the Study of Drug Development, Tufts University School of Medicine, where he conducts grant-funded research on pharmaceutical R&D management and execution; protocol design optimization, contract service provider and investigative site management, e-clinical technology and data usage and patient engagement. He is the chairman of CISCRP – a nonprofit organization that he founded to educate and raise public and patient awareness of the clinical research enterprise. A well-known speaker at conferences, symposia, universities, investor meetings and corporations, Ken has published extensively in peer-review journals, books and in the trade press and writes a bi-monthly column nominated for a Neal Award in Applied Clinical Trials. Ken received an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and a bachelor’s degree, Phi Beta Kappa, from Brandeis University. He is the founder of CenterWatch, a leading publisher in the clinical trials industry, and one of several businesses that he has created and sold.

Taqiyya Alford is a Clinical Research Coordinator at the Emory University School of Nursing and Operations Manager with the Emory Urban Health Initiative. She currently manages two studies at the Nell Hodgson Woodruff School of Nursing and has a diverse background in rehabilitation, clinical research, and pharmaceutical work. She is a recent Masters in Public Health graduate of South University in Savannah, GA.

For more information about the Tufts Center for the Study of Drug Development, the future of clinical triels, and the “Last Mile” for COVID vaccination, access the links below:

1. https://www.appliedclinicaltrialsonline.com/
2. https://www.appliedclinicaltrialsonline.com/view/covid-19-and-its-impact-on-the-future-of-clinical-trial-execution
3. https://www.appliedclinicaltrialsonline.com/view/public-trust-and-the-last-mile-for-covid-19-vaccines
   

Information on the Emory University Nell Hodgson School of Nursing research:

https://nursing.emory.edu/faculty-and-research/onr/index.html